Agilent Technologies Inc (A)-Medical Equipment-Deals and Alliances Profile

Agilent Technologies Inc (A)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME3859D
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company offers its products to diagnostics, life sciences and applied chemical markets. It serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers' representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8

Agilent Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9

Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10

Agilent Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11

Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12

Agilent Technologies Inc, Medical Equipment, Deal Details 16

Asset Purchase 16

Dako To Acquire Intellectual Property Rights From System Dynamics 16

Private Equity 17

Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 17

Partnerships 17

Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 17

Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 18

Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 19

Agilent Technologies and Agendia Enter into Agreement 20

Agilent Technologies Enters into Agreement with Burning Rock Biotech 21

Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 21

Agilent Technologies Enters into Agreement with Eurofins Genomics 22

Agilent Technologies Enters into Agreement with 10X Genomics 23

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 23

Merck and Pfizer Enters into Agreement with Dako 24

Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 25

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 26

Agilent Extends Co-Marketing Agreement with MRM Proteomics 27

Dako Enters into Agreement with Merck for Companion Diagnostic Test 27

Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 28

Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 29

Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 30

Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 31

Agilent Enters Into Research Agreement With Chungnam National University 32

Agilent Technologies Enters Into Co-Development Agreement With Florida International University 33

Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 34

Dako Enters Into Agreement With Pfizer For Companion Diagnostics 34

Agilent Technologies Enters Into Research Agreement With Ameritox 35

Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 36

Advion Enters Into Technology Integration Agreement With Agilent Technologies 37

Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 38

Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 39

Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 39

Dako Enters Into Co-Development Agreement With Amgen 40

Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 41

Dako Enters Into Co-Development Agreement With Amgen 42

Dako Enters Into Co-Development Agreement With Bristol-Myers 43

Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 43

Dako Denmark Enters Into Co-Development Agreement With Epitomics 44

Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 45

Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 45

Eppendorf Enters Into Licensing Agreement With Agilent Technologies 46

Debt Offering 47

Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 47

Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 48

Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 49

Asset Transactions 51

BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 51

Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 52

Acquisition 53

Agilent Technologies Acquires Multiplicom for USD72 Million 53

Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 54

Agilent Technologies Acquires Seahorse Bioscience for USD235 Million 54

Agilent Technologies Acquires Cartagenia for USD68.34 Million 55

Agilent Technologies To Acquire ABC Instrumentacion Analitica 56

Leica Biosystems Completes Acquisition Of Aperio Technologies 57

Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 58

Agilent Technologies Completes Acquisition Of BioSystem Development 60

Agilent Technologies Acquires P.V.R. 61

Agilent Technologies Acquires Lab901 62

Agilent Technologies Inc-Key Competitors 64

Key Employees 65

Locations And Subsidiaries 67

Head Office 67

Other Locations & Subsidiaries 67

Recent Developments 68

Strategy And Business Planning 68

Nov 30, 2016: Agilent Technologies Opens Folsom Technology Center 68

Financial Announcements 69

May 22, 2017: Agilent Technologies Reports Second-Quarter Fiscal Year 2017 Financial Results 69

Feb 14, 2017: Agilent Technologies Reports First-Quarter 2017 Results 70

Nov 15, 2016: Agilent Technologies Reports Fourth-Quarter 2016 Results 71

Aug 17, 2016: Agilent Technologies Reports Third-Quarter 2016 Results 72

May 16, 2016: Agilent Technologies Reports Second-Quarter 2016 Results 73

Feb 16, 2016: Agilent Technologies Reports First-Quarter 2016 Results 74

Corporate Communications 75

May 04, 2017: Agilent Technologies Receives Multiple Awards at Scientific Conference in China 75

Mar 20, 2017: Agilent Technologies Hires Samraat Sam Raha to Head Strategy and Corporate Development 76

Mar 15, 2017: Agilent Technologies Board of Directors Elects Koh Boon Hwee as New Chairman 77

Mar 14, 2017: Agilent Technologies Receives 2017 Scientists' Choice Award for Best Webinar Series 78

Feb 21, 2017: Agilent Technologies Receives Dow Western Canada Science and Technical Excellence Conference Awards (WesTEC) for Technical Excellence and Innovation 79

Dec 21, 2016: Agilent Technologies Receives Top Innovation Award from The Analytical Scientist 80

Mar 17, 2016: Agilent Technologies Receives Award for Outstanding Customer Service for Second Straight Year 81

Jan 27, 2016: Agilent Technologies Wins Award for Innovation in Liquid Chromatography 82

Jan 06, 2016: Agilent Technologies Names Michael Tang Senior Vice President, General Counsel and Secretary 83

Legal and Regulatory 84

Jan 11, 2017: Applied Spectral Imaging announced that its GenASIs applications comply with CE-IVD requirements with the IQFISH lung cancer panel on Dako Omnis of Agilent Technologies 84

Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies 85

Product News 86

Jun 19, 2017: Agilent Technologies Unveils New Analytical and Purification Solutions at HPLC 2017 86

Jun 05, 2017: Prosolia DESI 2D Molecular Imaging Now Compatible with Agilent Technologies 87

Oct 10, 2016: Agilent Technologies showcases innovative laboratory solutions at analytica China 2016 88

May 03, 2016: Agilent Technologies Introduces New Atomic Spectroscopy Platform for Multiple Analytical Applications 89

Apr 27, 2016: Agilent Technologies Statement-the Blueprint Project 90

Mar 09, 2016: Agilent Technologies Launches New Platform for Analyzing Cell-Free DNA 91

Jan 26, 2016: Agilent Technologies Showcases New Solutions at Biopharmaceutical Symposium 92

Other Significant Developments 93

Dec 21, 2016: Rubicon Genomics Signs Supply Agreement With Agilent Technologies For Its PicoPLEX WGA Kit 93

Oct 19, 2016: Jubilant Biosys Becomes the First Company in India to Install Agilent RapidFire/MS Screening Platform 94

Jul 28, 2016: Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research 95

Mar 14, 2016: Agilent Publishes Overview of Best Practices for Breast Cancer Diagnosis 96

Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 97

Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 98

Jan 19, 2016: Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips 99

Appendix 100

Methodology 100

About GlobalData 100

Contact Us 100

Disclaimer 100

List of Figures

Agilent Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Agilent Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8

Agilent Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 9

Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10

Agilent Technologies Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 11

List of Tables

Agilent Technologies Inc, Medical Equipment, Key Facts, 2016 1

Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8

Agilent Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9

Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10

Agilent Technologies Inc, Deals By Market, 2011 to YTD 2017 11

Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12

Dako To Acquire Intellectual Property Rights From System Dynamics 16

Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 17

Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 17

Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 18

Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 19

Agilent Technologies and Agendia Enter into Agreement 20

Agilent Technologies Enters into Agreement with Burning Rock Biotech 21

Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 21

Agilent Technologies Enters into Agreement with Eurofins Genomics 22

Agilent Technologies Enters into Agreement with 10X Genomics 23

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 23

Merck and Pfizer Enters into Agreement with Dako 24

Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 25

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 26

Agilent Extends Co-Marketing Agreement with MRM Proteomics 27

Dako Enters into Agreement with Merck for Companion Diagnostic Test 27

Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 28

Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 29

Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 30

Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 31

Agilent Enters Into Research Agreement With Chungnam National University 32

Agilent Technologies Enters Into Co-Development Agreement With Florida International University 33

Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 34

Dako Enters Into Agreement With Pfizer For Companion Diagnostics 34

Agilent Technologies Enters Into Research Agreement With Ameritox 35

Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 36

Advion Enters Into Technology Integration Agreement With Agilent Technologies 37

Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 38

Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 39

Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 39

Dako Enters Into Co-Development Agreement With Amgen 40

Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 41

Dako Enters Into Co-Development Agreement With Amgen 42

Dako Enters Into Co-Development Agreement With Bristol-Myers 43

Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 43

Dako Denmark Enters Into Co-Development Agreement With Epitomics 44

Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 45

Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 45

Eppendorf Enters Into Licensing Agreement With Agilent Technologies 46

Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 47

Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 48

Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 49

BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 51

Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 52

Agilent Technologies Acquires Multiplicom for USD72 Million 53

Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 54

Agilent Technologies Acquires Seahorse Bioscience for USD235 Million 54

Agilent Technologies Acquires Cartagenia for USD68.34 Million 55

Agilent Technologies To Acquire ABC Instrumentacion Analitica 56

Leica Biosystems Completes Acquisition Of Aperio Technologies 57

Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 58

Agilent Technologies Completes Acquisition Of BioSystem Development 60

Agilent Technologies Acquires P.V.R. 61

Agilent Technologies Acquires Lab901 62

Agilent Technologies Inc, Key Competitors 64

Agilent Technologies Inc, Key Employees 65

Agilent Technologies Inc, Subsidiaries 67

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Agilent Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16065
Site License
USD 500 INR 32130
Corporate User License
USD 750 INR 48195

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com